American Financial Group Inc Nurix Therapeutics, Inc. Transaction History

American Financial Group Inc

  • $233 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022
SELL
$12.94 - $29.65 $96,299 - $220,655
-7,442 Closed
0 $0
Q3 2021

Nov 05, 2021
BUY
$22.71 - $36.69 $169,007 - $273,046
7,442 New
7,442 $223,000
Q2 2021

Aug 06, 2021
SELL
$24.21 - $35.89 $360,341 - $534,186
-14,884 Closed
0 $0
Q1 2021

May 11, 2021
BUY
$26.98 - $50.17 $401,570 - $746,730
14,884 New
14,884 $462,000

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.04B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track American Financial Group Inc Portfolio

Follow American Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email